Cycads: A comprehensive review of its botany, traditional uses, phytochemistry, pharmacology and toxicology.

Chinese traditional medicines Cycads Cycas revoluta Ethnobotanical uses Gymnosperm Natural product discovery Pharmacological activity

Journal

Phytochemistry
ISSN: 1873-3700
Titre abrégé: Phytochemistry
Pays: England
ID NLM: 0151434

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 11 10 2023
revised: 21 01 2024
accepted: 22 01 2024
medline: 18 3 2024
pubmed: 30 1 2024
entrez: 29 1 2024
Statut: ppublish

Résumé

Cycads, which primarily consist of the families Cycadaceae and Zamiaceae, possess intrinsic therapeutic attributes that are prominently expressed across their morphological spectrum, including roots, leaves, flowers, and seeds. In Chinese traditional medicine, the leaves of cycads are particularly revered for their profound healing capabilities. This meticulous review engages with existing literature on cycads and presents insightful avenues for future research. Over 210 phytoconstituents have been isolated and identified from various cycad tissues, including flavonoids, azoxy metabolites, sterols, lignans, non-proteogenic amino acids, terpenoids, and other organic constituents. The contemporary pharmacological discourse highlights the antineoplastic, antimicrobial, and antidiabetic activities inherent in these ancient plants, which are of particular importance to the field of oncology. Despite the prevalent focus on crude extracts and total flavonoid content, our understanding of the nuanced pharmacodynamics of cycads lags considerably behind. The notoriety of cycads derived toxicity, notably within the context of Guam's neurological disease cluster, has precipitated an established emphasis on toxicological research within this field. As such, this critical review emphasizes nascent domains deserving of academic and clinical pursuit, whilst nested within the broader matrix of current scientific understanding. The systematic taxonomy, traditional applications, phytochemical composition, therapeutic potential, and safety profile of cycads are holistically interrogated, assimilating an indispensable repository for future scholarly inquiries. In conclusion, cycads stand as a veritable treasure trove of pharmacological virtue, displaying remarkable therapeutic prowess and holding vast promise for ongoing scientific discovery and clinical utilization.

Identifiants

pubmed: 38286200
pii: S0031-9422(24)00038-4
doi: 10.1016/j.phytochem.2024.114001
pii:
doi:

Substances chimiques

Phytochemicals 0
Plant Extracts 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114001

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing interest The authors declare that there have no conflicts of interest.

Auteurs

Qinyun Du (Q)

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

Nan Xing (N)

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

Sa Guo (S)

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

Rui Li (R)

Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Meishan, 620010, China.

Xianli Meng (X)

Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: xlm999@cdutcm.edu.cn.

Shaohui Wang (S)

Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Meishan, 620010, China; School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: winter9091@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH